Gp-100 as a Novel Therapeutic Target in Uveal Melanoma

Gp-100 as a Novel Therapeutic Target in Uveal Melanoma

Uveal melanoma is a rare neoplasm with poor prognosis in the metastatic setting. Unlike cutaneous melanoma, treatment with kinase inhibitors or immune checkpoint inhibitors is not effective. Glycoprotein 100 (Gp-100) is a protein highly expressed in melanocytes and melanoma that has recently been ef...

Full description

Bibliographic Details
Main Authors: Daniel Martinez-Perez, David Viñal, Isabel Solares, Enrique Espinosa, Jaime Feliu
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cancers
Subjects:
uveal melanoma
tebentafusp
glycoprotein 100
Online Access:https://www.mdpi.com/2072-6694/13/23/5968

Similar Items

Similar Items